K
Klotho Neurosciences, Inc. (KLTO)
NCM – Real vaqt narxi. Valyuta: USD
0.52
+0.00 (0.81%)
Yopilishda: Mar 11, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.52
+0.00 (0.81%)
Yopilishda: Mar 11, 2026, 4:00 PM EDT
Klotho Neurosciences, Inc. saraton, yurak-qon tomir va neyrodegenerativ kasalliklarni davolash uchun dori vositalarini ishlab chiqadi. Uning yetakchi gen terapiyasi mahsulot nomzodlari Altsgeymer kasalligini davolash yoki oldini olish uchun KLTO-101; va Lou Gehrig kasalligini davolash va oldini olish uchun gen terapiyasi mahsuloti KLTO-202ni o'z ichiga oladi. Kompaniya ilgari Anew Medical, Inc. nomi bilan tanilgan va 2024-yil sentyabr oyida Klotho Neurosciences, Inc. nomini o'zgartirgan. Klotho Neurosciences, Inc. Omaha, Nebraska shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joseph A. Sinkule Pharm.D. | Founder, CEO, Chairman of the Board & Secretary |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant |
| Dr. Shalom Z. Hirschman M.D. | Medical Advisor & Director |
| Mr. Jeffrey LeBlanc | Chief Financial Officer |
| Mr. Peter J. Moriarty | Chief Business Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-26 | DEFR14A | ea0272598-03.htm |
| 2026-01-23 | DEF 14A | ea0272598-02.htm |
| 2026-01-12 | PRE 14A | ea0272598-01.htm |
| 2025-12-08 | 8-K | ea0268846-8k_klotho.htm |
| 2025-12-05 | S-1 | ea0268254-s1_klotho.htm |
| 2025-11-13 | 10-Q | ea0264459-10q_klotho.htm |
| 2025-11-06 | S-8 | ea0261864-s8_klotho.htm |
| 2025-09-25 | 8-K | ea0258847-8k_klotho.htm |
| 2025-08-18 | 10-Q | ea0253157-10q_klotho.htm |
| 2025-08-14 | NT 10-Q | ea0253155-nt10q_klotho.htm |